An Antibody Treatment Combats Life-Threatening Sepsis in Rodents (2 of 2) (VIDEO)

American Association for the Advancement of Science (AAAS)

Caption

This video describes the results of a recent study by Weiqiang Chen and colleagues that links the protein tetranectin to the potentially lethal outcomes of sepsis - with potential relevance for secondary bacterial infections in COVID-19 patients. This material relates to a paper that appeared in the Apr. 15, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by W. Chen at Northwell Health in Manhasset, NY; and colleagues was titled, "Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis."

Credit

[Credit: Dr. Haichao Wang with technical assistance from Zoe Wang and Echo Wang]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.